Aim To compare the formation of fibrous capsules around Biodentine and MTA Angelus implants as well as the participation of fibroblast growth factor-1 (FGF-1) and mast cells in the tissue response to these endodontic materials. Methodology Sixty polyethylene tubes filled with Biodentine or MTA, and empty tubes (control group) were implanted into the dorsal subcutaneous tissues of male rats. After 7, 15, 30 and 60 days, the specimens were embedded in paraffin and the number of fibroblasts and mast cells was quantified in the sections stained with Masson's trichrome or Alcian Blue, respectively. FGF-1 and Ki-67 were detected by immunohistochemistry, and the number of immunolabelled cells was computed. The collagen content was estimated in the picrosirius red-stained sections. The data were subjected to two-way ANOVA followed by Tukey's test (P ≤ 0.05).
Aim To compare the formation of fibrous capsules around Biodentine and MTA Angelus implants as well as the participation of fibroblast growth factor-1 (FGF-1) and mast cells in the tissue response to these endodontic materials. Methodology Sixty polyethylene tubes filled with Biodentine or MTA, and empty tubes (control group) were implanted into the dorsal subcutaneous tissues of male rats. After 7, 15, 30 and 60 days, the specimens were embedded in paraffin and the number of fibroblasts and mast cells was quantified in the sections stained with Masson's trichrome or Alcian Blue, respectively. FGF-1 and Ki-67 were detected by immunohistochemistry, and the number of immunolabelled cells was computed. The collagen content was estimated in the picrosirius red-stained sections. The data were subjected to two-way ANOVA followed by Tukey's test (P ≤ 0.05).
Results The capsules were associated with a significant increase (P < 0.0001) in the number of fibroblasts and mast cells, and in the collagen content over time. A significant decrease (P < 0.0001) in the immunoexpression of FGF-1 and Ki-67 was observed in all groups from the 7th-60th day. At 60 days, the number of fibroblasts (P = 0.0226) and the collagen content (P < 0.0001) were significantly greater in MTA than Biodentine specimens, while the greatest number of mast cells and FGF-1-immunolabelled cells was observed in Biodentine specimens (P < 0.0001). A significant difference in Ki-67 immunoexpression was not detected between specimens of Biodentine and MTA. Conclusions The collagen-rich capsule formed slowly around Biodentine in comparison with MTA. FGF-1 and mast cells participated in capsule remodelling, stimulating fibroblast proliferation and
Introduction
Mineral Trioxide Aggregate (MTA) is a calcium silicate-based root repair cement indicated for sealing both root and furcation perforations (da Silva et al. 2011 , Katsamakis et al. 2013 , root-end filling (Tanomaru-Filho et al. 2009 ) and pulp capping (Nowicka et al. 2013) . MTA is a biocompatible material (Shahi et al. 2010 , da Silva et al. 2011 , Viola et al. 2012 , Silva et al. 2015 , da Fonseca et al. 2016 which has a good bacterial sealing ability (Espir et al. 2016) . However, this cement has a long setting time and handling difficulty (Roberts et al. 2008) .
Biodentine (Septodont â Inc., Saint-Maur-des-Foss es, France) is a reparative calcium silicate-based biomaterial launched as an alternative to MTA with similar indications (Laurent et al. 2008 , Han & Okiji 2013 , and also as a restorative material (Raskin et al. 2012) .
The main powder component of Biodentine is highpure tricalcium silicate, while its liquid is an aqueous solution containing calcium chloride to accelerate setting time, and polycarboxylate, providing good fluidity and consistence (Camilleri et al. 2013) .
Reparative cements remain in close contact with periodontal and pulp tissues. So, it is necessary to understand the cellular events established between biomaterials and the tissues. The sequence of the inflammatory processes induced by calcium-silicate cements is relatively well-known (Sarkar et al. 2005 , Shahi et al. 2010 , da Silva et al. 2011 , Viola et al. 2012 , Nowicka et al. 2013 , Silva et al. 2015 , da Fonseca et al. 2016 , Saraiva et al. 2018 . However, cellular and molecular mechanisms involved in replacing the inflammatory reaction by healthy connective tissue, as observed in the repair process, are still poorly understood.
The initial tissue response to implanted biomaterials is the initiation of an inflammatory reaction that releases mediators, such as cytokines and growth factors, and subsequent recruitment of leucocytes, which modulate tissue repair (Williams 2008) . Thus, the host response to substances released by biomaterials interferes with the intensity and duration of the inflammatory process (Anderson et al. 2008) . The regression of the inflammatory process accompanied by formation of collagen-rich capsules surrounding implanted materials is indicative of biocompatibility (Thevenot et al. 2011 , Silva et al. 2017 , Saraiva et al. 2018 .
The implantation of biomaterials leads to the activation of mast cells (Thevenot et al. 2011) . It has been reported that these cells participate in the inflammatory and reparative processes (Ng 2010) , since these cells produce and release several mediators, such as interleukin-6, prostaglandins, vascular endothelial growth factor, tumoral necrosis factor a (Norrby 2002 , Theoharides et al. 2012 and matrix metalloproteinases (Norrby 2002 , Cerri et al. 2010 , Theoharides et al. 2012 . In addition, during wound healing several factors may stimulate fibroblast proliferation. Among them, fibroblast growth factor-1 (FGF-1), also known as acidic fibroblast growth factor, is a growth factor expressed by several cell types, including fibroblasts. This factor has a fundamental role in reparative process due to mitogenic and angiogenic actions (Zakrzewska et al. 2008) . Ki-67 is a non-histone nuclear cortex protein expressed during the G1, S, G2, and M phases of the cell cycle, but not in quiescent state cells (Penault-Llorca & RadosevicRobin 2017) . Ki-67 can be a surrogate measure of biocompatibility (Silva et al. 2013 , Ledda et al. 2015 since cell proliferation after implantation of materials could be an indicator of tissue repair.
In this study, the formation of the fibrous capsule in response to Biodentine and MTA implantation in rat subcutaneous tissues was compared and the potential role of mast cells in the tissue response to these endodontic materials was assessed. Whether Ki-67 and the mitogenic factor FGF-1 are associated with fibroblast proliferation and, therefore, have a participation in the remodelling process of capsules were also investigated. The null hypothesis was that Biodentine and MTA would not induce collagen formation and that FGF-1 and Ki-67 would not participate in the remodelling process of the capsules over time.
Materials and methods

Experimental procedures
The animal care and the experimental procedures were conducted in accordance with Brazilian national law on animal use. The protocol of this study was approved by the Ethical Committee for Animal Research of Araraquara Dental School, UNESP, Brazil.
Sixty adult male Holtzman rats (Rattus norvegicus albinus) were housed individually in stainless steel cages in a room with controlled temperature (23 AE 2°C) and humidity (55 AE 10%) under a 12 h light/12 h dark cycle with onset at 7:00 AM. The rats received water and food (Guabi rat chow, Paul ınia, SP, Brazil) ad libitum.
The animals were distributed into three groups containing 20 animals each: Biodentine (Septodont and xylazine (8 mg kg À1 of body weight). The dorsal skin was shaved and disinfected with 5% iodine solution. A 2.0 cm-long incision was performed and one polyethylene tube was placed into the subcutaneous pocket. After 7, 15, 30 and 60 days of implantation, the rats were killed by an overdose of ketamine and the tubes surrounded by connective tissue were removed (n = 5/group/period) and, immediately, immersed in the fixative solution.
Histological procedures
After fixation for 48 h in 4% formaldehyde at pH 7.2 buffered with 0.1 mol L À1 sodium phosphate at room temperature, the specimens were dehydrated and embedded in paraffin. From each implant, 60 longitudinal sections (6 lm thick) were carried out; five nonserial sections were stained with Masson's trichrome for morphological analysis of the capsules adjacent to the orifices of the tubes containing the material. Sections were submitted to the Alcian Blue (AB) method pH 2.5 and the number of mast cells in the capsules was estimated. Birefringent collagen content was measured from sections stained with picrosirius method. Sections adhered to silanized slides were subjected to immunohistochemistry for detection of fibroblast growth factor-1 (FGF-1) and Ki-67; the numerical density of FGF-1-and Ki-67-immunolabelled cells in the capsules was also computed.
Morphological analysis and numerical density of fibroblasts
The morphological evaluation and fibroblast number in the capsules were performed from sections stained with Masson's trichrome (Silva et al. 2017) . For each implant, three non-serial sections, at intervals of at least 100 lm, were used. In each section, a standardized area (0.09 mm 2 ), in the central portion of the capsule in close juxtaposition to the tube opening, was captured using a camera (DP71, Olympus, Tokyo, Japan) attached to a light microscope (BX51, Olympus) at 9695 magnification. The number of fibroblasts (fusiform cells) was counted using an image analysis system (Image Pro-Express 6.0, Olympus). For each implanted tube, the fibroblasts were counted in the total area of 0.27 mm 2 , and the number of fibroblasts per mm 2 was estimated (Viola et al. 2012 , Silva et al. 2014 , da Fonseca et al. 2016 .
Numerical density of mast cells in the capsules
For each specimen, two non-serial sections were immersed in a solution of 1% AB 8GX (Sigma-Aldrich Chemie, Munich, Germany) dissolved in 3% aqueous acetic acid (pH 2.5) for 30 min. After washing in running tap-water for 10 min, the sections were counterstained with Carazzi's haematoxylin. Numerical density of mast cells exhibiting AB-positive granules (turquoise-blue colour) was estimated in all specimens (implants). In each section, two standardized areas (0.36 mm 2 each) of the capsule adjacent to the opening of implanted tube were captured using a camera (DP71, Olympus) attached to a light microscope (BX51, Olympus) at 9345 magnification. The number of mast cells was computed using an image analysis system (Image Pro-Express 6.0, Olympus). For each implanted tube, the number of mast cells was counted in the standardized area (totalling 1.44 mm 2 per implant) and the number of mast cells mm À2 was obtained.
Immunohistochemical detection of FGF-1 and Ki-67
Sections adhered to silanized slides were subjected to immunohistochemistry for the detection of FGF-1 or Ki-67. For antigen retrieval, the deparaffinized sections were immersed in 0.001 mol L À1 sodium citrate buffer pH 6.0, and submitted to microwave oven treatment for 20 min at 90-94°C. After a cooling-off period, the endogenous peroxidase was blocked with 5% hydrogen peroxide for 20 min. After washing in 0.1 mol L À1 sodium phosphate buffer (PBS) at pH 7.2, the sections were incubated for 30 min in 2% bovine-serum-albumin (Sigma-Aldrich Chemie) at room temperature. Then, the sections were incubated in a humidified chamber at 4°C for 16-18 h with mouse monoclonal anti-FGF-1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted at 1:150, or rabbit monoclonal anti-Ki-67 antibody (Spring Bioscience Corp., Pleasanton, CA, USA) diluted at 1:200. After washing in PBS, the immunoreactions were detected by the Labelled StreptAvidin-Biotin system (LSAB + System-HRP Kit; Dako, Carpinteria, CA, USA). The sections were
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incubated for 20 min at room temperature with a multi-link solution containing biotinylated mouse/rabbit/goat antibodies, washed in PBS and incubated with streptavidin-peroxidase complex for 20 min at room temperature. Peroxidase activity was revealed by 3,3 0 -diaminobenzidine (DAB, Biocare Medical Inc., Concord, CA, USA) for 3 min; the sections were counterstained with Carazzi's haematoxylin. In some sections used as negative controls, the step of incubation in primary antibodies was replaced by incubation in non-immune serum (Sigma-Aldrich Chemie).
Numerical density of FGF-1-and Ki-67-immunolabelled cells
For each specimen, two non-serial sections were used. In each section, a standardized area (0.09 mm 2 ) was captured using a camera (DP71, Olympus) attached to a light microscope (BX51, Olympus) at 9695 magnification. The number of immunolabelled cells (brownyellow colour) was computed using an image analysis system (Image Pro-Express 6.0, Olympus). For each implanted tube, the immunolabelled cells (FGF-1-and Ki-67-positive cells) were counted in the standardized area of capsule and the number of immunolabelled cells for FGF-1 and Ki-67 per mm 2 was obtained (Viola et al. 2012 , Silva et al. 2014 , da Fonseca et al. 2016 .
Content of birefringent collagen in the capsules
For the collagen content estimation in the capsules, the sections were stained with 0.1% picrosirius red solution and analysed under light microscope (BX51, Olympus) equipped with filters to provide polarized illumination. In each specimen, two non-serial picrosirius red-stained sections were used at intervals of at least 100 lm, totalling 10 sections per group in each period. In each section, a standardized area (0.09 mm 2 ) of the capsule was obtained at 9695 magnification, totalling an area of 0.18 mm 2 per implant. Birefringent collagen frequency was estimated using ImageJ â image analysis software (http://rsbweb.nih.
gov/ij) following a methodology previously described (Manni et al. 2011) . Data of each hue (red, orange, yellow and green) was determined and expressed as percentage of the total number of collagen pixels which in turn was expressed as a percentage of the total number of pixels in the image (Koshimizu et al. 2013 , Silva et al. 2017 , Saraiva et al. 2018 .
Statistical analysis
Statistical analyses were performed using the GraphPad Prism 6.01 software (GraphPad Software, Inc., La Jolla, CA, USA). Numerical density of fibroblasts, mast cells, FGF-1-immunolabelled cells, Ki-67-immunolabelled cells and the content of birefringent collagen were subjected to the D'Agostino-Pearson omnibus normality test, which detected normal Gaussian distribution of the data. Differences among the groups in each period as well as differences of each group over time were evaluated by two-way ANOVA analysis and post-hoc Tukey test. The accepted significance level was P ≤ 0.05.
Results
Morphological analysis and numerical density of fibroblasts
At 7 days, the capsules of all the groups had few fibroblasts among several inflammatory cells and blood vessels (Fig. 1a-c ). An evident reduction in the cellular density and an increase in the extracellular matrix components were observed in the capsules at 15 days ( Fig. 1d-f) . After 30 and 60 days, the capsules contained several fibroblasts among collagen fibres; few inflammatory cells, lymphocytes and macrophages, were seen in the capsules, particularly after 60 days (Fig. 1g-l) . According to Fig. 2 , a significant increase in the number of fibroblasts was observed in all groups over time. In all time points, the number of fibroblasts was Figure 2 Graphic showing the data (expressed as mean AE standard deviation) of the number of fibroblasts per mm 2 in the capsules of Biodentine, MTA and control groups at 7, 15, 30 and 60 days. The comparison amongst groups in the same period is indicated by superscript letters; same letters = no significant difference. The analysis of each group over time is indicated by superscript number; same numbers = no significant difference. Tukey's test (P ≤ 0.05).
significantly higher (P ≤ 0.0226) in the MTA than Biodentine specimens. At all periods, the greatest values were found in the capsules of the control group.
Alcian Blue-positive mast cells in the capsules
The Alcian Blue (AB) histochemical method revealed AB-positive (turquoise colour) mast cells in the capsules of all groups, mainly in the outer portion of the capsules (Fig. 3a-f) . However, an accentuated presence of these cells was observed in the capsules at 60 days ( Fig. 3d-f ). The quantitative analysis (Fig. 4) revealed that the lowest values of mast cells were found in the capsules at 7 days. A significant increase in the number of mast cells was observed in the capsules of all groups over time (P < 0.0001). Significant differences among the groups were not detected at any period, except at 60 days. In this period, the number of mast cells was significantly greater in Biodentine than MTA specimens (P < 0.0001) and the control group (P = 0.0003).
Numerical density of FGF-1 and Ki-67 immunolabelled cells
The sections subjected to FGF-1 immunohistochemical detection revealed immunolabelled cells (brown-yellow colour) in the capsules of all groups and periods ( Fig. 5a-l) . FGF-1-positive immunolabelling was observed in fibroblasts, mast cells and inflammatory cells at all time points. However, an enhanced immunoexpression was seen in the capsules of all groups at 7 days. According to Fig. 6 , the capsules of all groups exhibited the highest values of FGF-1-immunolabelled cells at 7 days. Moreover, in all groups a significant reduction in the immunolabelling was detected over time (P < 0.0001). However, the number of immunolabelled cells was significantly higher (P < 0.0001) in the capsules of Biodentine than in MTA and control groups in all time points. In the MTA specimens, the immunoexpression was significantly lower than the control group at 7 and 15 days (P < 0.0001) whereas significant differences were not observed between these groups after 30 (P = 0.9871) and 60 days (P = 0.7245).
With regard to Ki-67 immunohistochemical detection, some fibroblasts exhibiting nuclear immunolabelling (brown-yellow colour) were observed in the capsules of different groups in all time-points ( Fig. 7a-f) . The quantitative analysis (Fig. 7g) showed that the greatest value of Ki-67-immunolabelled cells was found in the capsules of all groups at 7 days. However, the immunolabelling was significantly higher in the Biodentine than MTA specimens at 7 (P < 0.0001) and 15 days (P = 0.0025) whereas significant differences were not observed between these groups at 30 (P = 0.7291) and 60 days (P = 0.4207). After 60 days, no significant difference among Biodentine, MTA and control groups was detected (P ≥ 0.2363).
Content of birefringent collagen in the capsules
At 7 days, the capsules exhibited scarce and thin birefringent collagen fibres (Fig. 8a-c) . Otherwise, an accentuated birefringence was observed in the capsules of all groups at 60 days (Fig. 8d-f) . According to Fig. 8g , the capsules of all groups revealed a significant increase (P < 0.0001) in the content of birefringent collagen over time. However, at 30 and 60 days the collagen content was significantly lower in the capsules of Biodentine than in MTA specimens (P < 0.0001) and the control group (P < 0.0001). Moreover, there was no significant difference (P = 0.4958) between MTA and control at 60 days.
Discussion
The results reveal that Biodentine was associated with slower collagen formation in comparison with MTA after implantation in the subcutaneous tissues of rats. Considering that FGF-1 stimulates collagen formation, it is conceivable that Biodentine interferes in collagen formation by reducing FGF-1 immunoexpression since the number of immunolabelled cells in the capsules of Biodentine was lower than the control group at 7 and 15 days. In addition, the significant increase in the number of mast cells accompanied by the increase in the collagen content in all groups, including the control group, indicates that these cells participate in the remodelling process of the capsules.
The increase in the number of fibroblasts concomitant with the regression of the inflammatory process was evident in the capsules adjacent to both calcium silicate materials and in the control group. Since Ki-67 is a marker of cell proliferation (Denkert et al. 2015 , Penault-Llorca & Radosevic-Robin 2017 , the significant increase in the number of fibroblasts may be a result of the proliferative activity of resident fibroblasts and mesenchymal cells. Fibroblasts have a high proliferative capacity, allowing tissue repair and healing (Bainbridge 2013 , Martin & Nunan 2015 . In the present study, the reduction in the number of Ki-67-immunolabelled cells was accompanied by an increase in the number of fibroblasts in the capsules of all the groups over time. Considering that Biodentine initially induced higher proliferative activity than MTA and control groups, the significantly lower number of fibroblasts in the Biodentine group suggests Tissue reaction promoted by Biodentine da Fonseca et al.
that this material may release irritant molecules, which may promote a less favourable environment to the host tissues. Biodentine initially induces a higher inflammatory reaction in comparison to MTA (da Fonseca et al. 2016) . However, the reduction in the inflammatory reaction with no significant difference after 60 days of subcutaneous implantation indicates that this repair material has a suitable biological response over time (da Fonseca et al. 2016) . Here, an increase in the birefringent collagen content was also clearly observed from 7 to 60 days. Quantitative analysis of birefringent collagen revealed a significant increase in collagen content, emphasizing that both Biodentine and MTA allow dense connective tissue formation over time. The increase in collagen content within the capsules accompanied by evident reduction in the inflammatory reaction indicate that Biodentine and MTA Angelus may induce a response that culminates in tissue repair (Saraiva et al. 2018) and, therefore, these materials are biocompatible. Considering that FGF-1 has angiogenic and vasculogenic potential (Uriel et al. 2006 , Zakrzewska et al. 2008 , Moya et al. 2010 , the highest FGF-1 immunoexpression observed at 7 days in all groups may be associated with the onset of the inflammatory process. Proliferation of blood vessels is an important event in the establishment of granulation tissue (Martin & Leibovich 2005 , Tsirogianni et al. 2006 . Several factors interact with blood vessels interfering in their permeability and in the leukocytes diapedesis to connective tissue, where these cells exert their functions (Mutsaers et al. 1997 , Martin & Leibovich 2005 , M arton & Kiss 2014 ). The present findings revealed FGF-1-immunopositivity in inflammatory cells, as lymphocytes, plasma cells and macrophages, as well as some fibroblasts, as previously reported (Rossini et al. 2005 , Zakrzewska et al. 2008 , Silva et al. 2017 ). In the present study, a concomitant presence of FGF-1-positive cells and Ki-67-labelled cells was observed in the capsules of both calcium silicate materials and in the control group, reinforcing the concept that FGF-1 stimulates mitotic activity (Zakrzewska et al. 2008 , Silva et al. 2017 . The greatest immunoexpression for FGF-1 accompanied by accentuated Ki-67-immunolabelled cells found at 7 days indicates that FGF-1 may have stimulated fibroblast proliferation, explaining the significant and gradual increase of these cells in all groups. In fact, the greatest values of FGF-1-immunolabelled cells at 7 and 15 days coexisted with the greater number of fibroblasts in the control group than in the Biodentine and MTA groups. Thus, it is possible to suggest that the lower immunoexpression of FGF-1 in the Biodentine and MTA groups may be responsible for the reduced number of fibroblasts in the capsules around these materials when compared with the control group. In addition, the significant increase in the collagen content in the capsules over time indicates that FGF-1 may also stimulate fibroblast activity (Silva et al. 2017) .
The Alcian Blue histochemical method revealed the presence of mast cells in the capsules of all groups, mainly at 30 and 60 days. Mast cells granules exhibit a large amount of sulfated glycosaminoglycans, as heparin and chondroitin sulfate, which react strongly with Alcian Blue (Scott 1996 , Harem & Liman 2009 . It is known that mast cells release histamine, which participates in the establishment of inflammatory reaction (Theoharides et al. 2012) . Thus, the presence of mast cells in the capsules at 7 days aligns with the moderate inflammatory process observed in the capsules of Biodentine and MTA as well as in the control group. However, there is also evidence that mast cells participate in healing (Hermes et al. 2001 , Ng 2010 , Wulff & Wilgus 2013 and bone repair (Arias-Gallo et al. 2013) , producing and releasing several mediators, such as tryptase, transforming growth factor b and vascular endothelial growth factor (Ng 2010 , Kennelly et al. 2011 . In the present study, mast cells exhibited strong FGF-1 immunoexpression, a mitogenic factor, indicating that these cells may release FGF-1. It is possible to suggest that this factor stimulated fibroblast proliferation and subsequent collagen formation, being involved in the inflammatory Tissue reaction promoted by Biodentine da Fonseca et al.
reaction regression and its replacement by fibrous connective tissue. Mast cells-knockout mice are associated with a lack of fibrous capsule surrounding subcutaneously implanted biomaterials (Thevenot et al. 2011) , confirming that these cells play a fundamental role in collagen formation. The present results showed a significant and gradual increase in the number of mast cells and collagen content in the capsules around Biodentine and MTA similar to the control group. These findings reinforce the concept that mast cells may have a pivotal role in the modulation of inflammatory processes favouring the regression of the inflammatory reaction and collagen formation, participating in the healing process. At 60 days, capsules of Biodentine had lower collagen content and fewer fibroblasts than MTA and the control group while significant difference in the collagen content was not detected between MTA and the control group. Therefore, these findings indicate that the regression of the inflammatory reaction and its replacement by collagen-rich capsule occurs more slowly around Biodentine in comparison with MTA and the control groups. However, in the capsules of Biodentine the number of FGF-1-positive cells remained accentuated in comparison with MTA and control groups, indicating that this mitogenic factor may still be acting on fibroblasts and, consequently, stimulating collagen formation. Moreover, the accentuated number of mast cells observed in the capsules of Biodentine at 60 days suggests that the factors released by these cells can also induce collagen formation. It is conceivable to suggest that differences observed in the tissue reaction promoted by Biodentine and MTA are due to the physicochemical properties of these materials. X-ray diffraction analysis of these non-hydrated cements revealed that MTA Angelus contains smaller quantity of tricalcium silicate than Biodentine (66.1% versus 80.1% in mass, respectively), resulting in a slower reaction rate (Camilleri et al. 2013) . Difference in the specific surface area measurement of the non-hydrated cements was also detected using the BET (Brunauer-Emmett-Teller) gas adsorption method. Although Biodentine contains tricalcium silicate of finer particle size, this material exhibits a higher specific surface area (m 2 g À1 ) than MTA (Camilleri et al. 2013) . Moreover, the higher solubility exhibited by Biodentine (Torres et al. 2017 ) may explain the delay in collagen formation as well as the maintenance of the accentuated FGF-1 immunoexpression and number of mast cells in the Biodentine group at 60 days. The calcium chloride present in Biodentine liquid also may partially explain this delay. When added to MTA, calcium chloride leads to a decrease in cell viability in comparison to pure water (Kang et al. 2013) . Despite its adequate biological response, Biodentine also elicits a slower regeneration of bone defects (Costa et al. 2016) . The increase in the birefringent collagen content, the fibroblast proliferation stated by Ki-67 and the regression of the inflammatory process indicate wound healing and consequently tissue repair, confirming that these materials are biocompatible. The results indicate that FGF-1 and mast cells participate in the remodelling process of the capsules stimulating fibroblast proliferation and subsequent collagen production. However, it is known that mast cells also produce and release several cytokines, growth factors and matrix metalloproteinases. These proteins perform a fundamental role in the remodelling of extracellular matrix components of the connective tissue. Therefore, future studies are required to clarify the exact participation of mast cells in the remodelling of the capsules in response to subcutaneous implantation.
Conclusions
Although the formation of collagen in response to Biodentine was slower in comparison with MTA, connective tissue fibrous capsules were formed around Biodentine, indicating that this material is biocompatible. FGF-1 and mast cells participated in capsule remodelling, stimulating fibroblast proliferation and subsequent collagen production, in response to subcutaneous implants in rats.
